Biocartis SA - Product Pipeline Analysis

1
Biocartis SA - Product Pipeline AnalysisMarket
Research Reports Distributor - Aarkstore.com have
vast database on market research reports, company
financials, company profiles, SWOT analysis,
company report, company statistics, strategy
review, industry report, industry research to
provide excellent and innovative service to our
report buyers.Aarkstore.com have very
interactive search feature to browse across more
than 2,50,000 business industry reports. We are
built on the premise that reading is valuable,
capable of stirring emotions and firing the
imagination. Whether you're looking for new
market research report product trends or
competitive industry analysis of a new or
existing market, Aarkstore.com has the best
resource offerings and the expertise to make sure
you get the right product every time.
2
Biocartis SA - Product Pipeline Analysis

• SummaryBiocartis SA (Biocartis) is a molecular
  diagnostics company. The company is focused on
  fast and low-cost integrated molecular and
  immunodiagnostics based on its micro-technology
  platform. The company has developed and licensed
  a series of new technologies to build a broadly
  applicable diagnostics platform for low to highly
  multiplexed detection, quantification, and
  amplification of bio-analytes, including
  proteins, nucleic acids and small molecules. The
  company is headquartered at Lausanne,
  Switzerland.This report is a source for data,
  analysis and actionable intelligence on the
  Biocartis SA portfolio of pipeline products. The
  report provides detailed analysis on each
  pipeline product with information on the
  indication, the development stage, trial phase,
  product milestones, pipeline territory, estimated
  approval date, and estimated launch dateEach
  pipeline product is profiled to cover information
  on product description, function, technology,
  indication, and application. The report is also
  supplemented with a detailed company profile and
  information on clinical trials, wherever
  applicable.This report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by GlobalDatas team of industry experts.

3

• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.- Profile of each pipeline
  product with additional information on product
  description, function, technology, indication(s),
  and application.- Data on relevant clinical
  trials and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 3List of Figures 3Key Facts
  4Biocartis SA - Major Products and Services
  5Biocartis SA Pipeline Products by Equipment
  Type 6Biocartis SA Pipeline Products by
  Development Stage 8Biocartis SA Pipeline
  Products by Therapy Area 10Biocartis SA Pipeline
  Products by Milestone Summary 12Apollo System
  13Apollo System Product Status 13Apollo System
  Product Description 13Apollo System Product
  Patent Details 13Apollo System - Neurological
  Disease Assay 15Apollo System - Neurological
  Disease Assay Product Status 15Apollo System -
  Neurological Disease Assay Product Description
  15Apollo System - Viral Infection 16Apollo
  System - Viral Infection Product Status 16Apollo
  System - Viral Infection Product Description
  16DMAT Platform 17DMAT Platform Product Status
  17DMAT Platform Product Description 17DMAT
  Platform Product Milestone 17DMAT Platform
  Product Patent Details 18DMAT Platform -
  Oncogene Panel Assay 19DMAT Platform - Oncogene
  Panel Assay Product Status 19DMAT Platform -
  Oncogene Panel Assay Product Description 19

5

• SeptiCyte Triage 20SeptiCyte Triage Product
  Status 20SeptiCyte Triage Product Description
  20Biocartis SA - Key Competitors 21Biocartis SA
  - Key Employees 22Biocartis SA - Locations And
  Subsidiaries 23Head Office 23Other Locations
  Subsidiaries 23Recent Developments 24Biocartis
  SA, Recent Developments 24Nov 30, 2011
  Biocartis Appoints Nayan Gregory Parekh As CEO
  24Jul 06, 2011 Biocartis Appoints Hilde Windels
  As CFO 24Jan 10, 2011 Biocartis Appoints Clark
  Harrison As COO 25Appendix 26Methodology
  26About GlobalData 26Contact Us 26Disclaimer
  26
• List of Tables Biocartis SA, Key Facts
  1Biocartis SA Key Pipeline Products by Equipment
  Type 1Biocartis SA Key Pipeline Products by
  Therapy Area 1Biocartis SA Key Pipeline Products
  by Development Stage 1Biocartis SA, Key Facts
  4Biocartis SA, Major Products and Services
  5Biocartis SA Number of Pipeline Products by
  Equipment Type 6Biocartis SA Pipeline Products
  by Equipment Type 7Biocartis SA Number of
  Pipeline Products by Development Stage
  8Biocartis SA Pipeline Products by Development
  Stage 9Biocartis SA Number of Pipeline Products
  by Therapy Area 10Biocartis SA Pipeline Products
  by Therapy Area 11Biocartis SA Number of
  Pipeline Products By Milestone Summary
  12Biocartis SA Pipeline Products by Milestone
  Summary 12

6
Apollo System - Product Status 13Apollo System
- Product Description 13Apollo System - Patent
Details1 13Apollo System - Neurological Disease
Assay - Product Status 15Apollo System -
Neurological Disease Assay - Product Description
15Apollo System - Viral Infection - Product
Status 16Apollo System - Viral Infection -
Product Description 16DMAT Platform - Product
Status 17DMAT Platform - Product Description
17DMAT Platform - Product Milestone 17DMAT
Platform - Patent Details1 18DMAT Platform -
Oncogene Panel Assay - Product Status 19DMAT
Platform - Oncogene Panel Assay - Product
Description 19SeptiCyte Triage - Product Status
20SeptiCyte Triage - Product Description
20Biocartis SA, Key Employees 22Biocartis SA,
Subsidiaries 23 List of Figures Biocartis SA
Key Pipeline Products by Equipment Type
1Biocartis SA Pipeline Products by Equipment
Type 6Biocartis SA Pipeline Products by
Development Stage 8Biocartis SA Pipeline
Products by Therapy Area 10Biocartis SA Pipeline
Products by Milestone Summary 12 
7

• For more information, please visit
• http//www.aarkstore.com/reports/Biocartis-SA-Prod
  uct-Pipeline-Analysis-240118.html
• Or email us at contact_at_aarkstore.com or call
  919272852585
• Related Reports
• 2013 French Hospital Hematology and Flow
  Cytometry Market
• United Arab Emirates In Vitro Diagnostics
  Investment Opportunities, Analysis and Forecasts
  to 2018
• Chile In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Norway In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Aleva Neurotherapeutics SA - Product Pipeline
  Analysis.
• DiaPat GmbH - Product Pipeline Analysis.
• Manhattan Scientifics, Inc. (MHTX) - Product
  Pipeline Analysis.
• MicroTransponder Inc. - Product Pipeline
  Analysis.
• Neurostream Technologies G.P. - Product Pipeline
  Analysis.
• Pop Test LLC - Product Pipeline Analysis.

8

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise